Skip to content
Home/Companies/Healthcare/Abacus Pharmaceuticals
AP

Abacus Pharmaceuticals

Healthcare·US·Active

Abacus Pharmaceuticals is a healthcare company, headquartered in USA.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns Abacus Pharmaceuticals?

Abacus Pharmaceuticals is currently owned by The Carlyle Group through Carlyle Sub-Saharan Africa Fund (2018 vintage).

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Sub-Saharan Africa Fund · 2018 · Buyout

Key facts

HQUSA
SectorHealthcare

More from Carlyle Sub-Saharan Africa Fund

Other portfolio companies in the same fund.

A Twosome Place
Active
ConsumerUS
Accolade Wines
Active
ConsumerAustralia
Amecor
Exited 2024
TMTUS
to
Amrod
Exited 2023
ConsumerUS
to
CMC Networks
Active
TMTSouth Africa
Every Man Jack
Active
ConsumerUS

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Acusurgical
Active
Supernova InvestFrance
Adagene
Active
General AtlanticChina
Data refreshed weekly · Sourced from public filings